Market Insights & Analysis
Stock Market Update for March 21st, 2024
March 21st, 2024
Global Markets Market Moves Analysis: Wall Street: Wall Street saw an upward trend, buoyed by strong gains in chipmakers, led by Micron Technology. The rally in semiconductor stocks reflected investor optimism surrounding the tech sector, despite ongoing concerns about supply chain disruptions and global chip shortages. Additionally, investors...
Impact of Social Media Financial Influencers on Retail Investors In recent years, social media platforms have become popular hubs for financial advice and investment discussions. A growing number of self-proclaimed financial influencers leverage these platforms to share their insights, strategies, and stock recommendations with retail...
Micron Stock Analysis: Stock becoming Overvalued?
March 21st, 2024
Micron Stock Analysis Micron's stock look like its starting to become overvalued, and requires a nuanced analysis of various factors, including analyst projections, stock performance, and market dynamics to determine the current analysis of this equity. Analyst Projections: According to the consensus of 20 analysts, the average target price...
Analysts Rate Nvidia with a “Consensus Strong Buy”
March 21st, 2024
Analyzing NVIDIA's Stock Forecast NVIDIA Corporation (NASDAQ: NVDA), a powerhouse in the realm of graphics processing units (GPUs) and artificial intelligence (AI), has been a focal point for investors seeking exposure to the ever-evolving tech landscape. As market sentiments fluctuate and industry dynamics shift, understanding the stock forecast...
352 Analyst Ratings for March 20th, 2024
March 20th, 2024
US/CDN/UK/IND Ratings Name Symbol Analyst Action Rating Target Price American Airlines Group AAL UBS Initiates Coverage On Buy USD 19 Adicet Bio Inc ACET Wedbush Securities Reiterated by Outperform - Outperform USD 5 Adicet Bio...
Nvidia Stock Analyst Coverage Analysts have revised their 12-month target forecasts on Nvidia's stock as follows: Citigroup: Raised their target from USD 820 to USD 1030 while maintaining a Buy rating on March 20, 2024. Goldman Sachs & Co.: Increased their target from USD 875 to USD 1000 with a Buy recommendation on March 20, 2024....
Biggest Gainers
Biggest Gainers
Biggest Gainers
Biggest Gainers
Price | 1 Week Change | |
---|---|---|
INR 230.50 |
-3.80 (-1.90%) |
|
INR 164.65 |
-4.50 (-3.01%) |
|
INR 259.95 |
-3.60 (-1.54%) |
|
INR 136.05 |
-2.10 (-1.71%) |
|
INR 3,129.95 |
-54.65 (-1.93%) |
Biggest Losers
Price | 1 Week Change | |
---|---|---|
INR 295.90 |
-6.10 (-1.56%) |
|
INR 3,466.40 |
-14.35 (-0.37%) |
|
INR 1,399.05 |
+2.65 (+0.18%) |
|
INR 4,436.40 |
+70.65 (+1.51%) |
|
INR 1,891.10 |
-26.50 (-1.30%) |
From the Investment Vault
Curated Articles based on your interest
Nvidia: Wall Street’s Top Stock to Watch in 2024
December 28th, 2023
Nvidia (NVDA: NSD) is considered by Wall Street analysts as the top stock pick for 2024. The company is a leading provider of graphics processing units (GPUs) and artificial intelligence (AI) technology, offering a wide range of applications, from gaming and data centers to autonomous vehicles and AI research. Its strong market position indicates...
Apple’s Smartwatch Business Gets A Boost After Court Decision
December 28th, 2023
Apple (AAPL: NSD) has received permission to continue selling its latest smartwatches after a temporary pause on the import ban imposed by the Federal Trade Commission. This recent development is a significant relief for the company, as it allows them to continue offering their popular product to consumers. AAPL Ratings by Stock Target...
Cytokinetics Stock Surges on Promising Phase 2 Trial Results
December 28th, 2023
Cytokinetics Inc's stock (CYTK: NSD) surged by over 30% after positive Phase 2 trial results of its lead drug candidate, omecamtiv mecarbil, for treating HFpEF. This indicates investors' growing confidence in Cytokinetics's innovative approach to treating the condition. CYTK Ratings by Stock Target Advisor Stock Target...
Disney and DeSantis Locked in Legal Battle Over RCID
December 28th, 2023
New lawsuits filed by Disney Company (DIS: NYE) and Florida Governor Ron DeSantis over Reedy Creek Improvement District (RCID) reignite their dispute. DIS Ratings by Stock Target Advisor Reedy Creek Improvement District Background: For decades, the RCID functioned as a self-governing entity managing Disney's Florida...
General Motors Stock Faces Decline amid Emerging Challenges
December 28th, 2023
General Motors (GM: NYE) experienced a decline in its stock price after the emergence of various issues. Investors are worried about how these issues could affect the company's performance. GM Ratings by Stock Target Advisor Stock Target Advisor’s Analysis on GM: Stock Target Advisor has identified some positive...
Analysts Rates Esports Entertainment Group Inc. as a Consensus “Neutral” Rating
December 22nd, 2023
GMBL Stock Analysis Esports Entertainment Group Inc's stock analysis indicates a slightly bearish outlook, driven by three positive signals and five negative signals. The closing price of the stock was USD 4.20. While the stock experienced an exceptional increase of +22,005.26% in the past week and +13,448.39% in the...
7 Analysts Adjust Coverage on Crescent Point Energy (CPG:TSX)
December 22nd, 2023
Analyst Ratings Coverage ATB Capital Markets reinstated coverage on Crescent Point Energy with an Outperform rating, setting a target price of CAD 13 on 12/22/2023. STA Research reiterated a Hold rating with a target price of CAD 10 on the same date. CIBC World Markets maintained an Outperform rating, establishing a target price of CAD 15...
Wedbush Boosts price target for Tesla from $310 to $350
December 22nd, 2023
Analyst Ratings Coverage: TSLA In a recent statement on Dec 21st at 6:21pm, Wedbush analyst Dan Ives announced an upward revision of the price target for Tesla from $310 to $350. This decision is rooted in an increasingly optimistic outlook on Tesla's future performance in the electric vehicle (EV) market. The key factors contributing to this...
Vodafone’s Italy Acquisition Rumors Trigger Surge in Shares
December 22nd, 2023
Vodafone (VOD: LSE) saw a significant surge in its shares following reports of potential talks with Swisscom regarding the acquisition of Vodafone's Italy unit. The news sent ripples through the market, capturing the attention of investors and industry experts alike. VOD:LSE Ratings by Stock Target Advisor Acquisition...
Why Johnson & Johnson is Primed for Growth in 2024
December 22nd, 2023
Johnson & Johnson (JNJ: NYE) stands as a globally recognized leader in the healthcare and consumer goods industries. The recent spin-off of its Consumer segment has paved the way for the company to concentrate on its core strengths, primarily in the Innovative Medicine and MedTech sectors. This strategic direction may result in growth...
Market News
Factbox-Top deals in the global mining sector
30 minutes ago